(Q37071265)

18 August 2017

1 reference

title

Probiotics in clinical practice: an overview (English)

1 reference

18 August 2017

0 references

G V Zuccotti

1

1 reference

18 August 2017

F Meneghin

2

1 reference

18 August 2017

C Raimondi

3

1 reference

18 August 2017

D Dilillo

4

1 reference

18 August 2017

C Agostoni

5

1 reference

18 August 2017

E Riva

6

1 reference

18 August 2017

M Giovannini

7

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Journal of International Medical Research

18 August 2017

published in

1 reference

18 August 2017

volume

36 Suppl 1

1 reference

18 August 2017

page(s)

1A-53A

1 reference

Probiotics to enhance anti-infective defences in the gastrointestinal tract

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The anatomy of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics and their potential health claims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Taxonomy and physiology of probiotic lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Nutritional impact of pre- and probiotics as protective gastrointestinal organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Antimicrobial substance from a human Lactobacillus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Pro- and prebiotics--the tasty guardian angels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Immune System Stimulation by Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in primary care pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus GG and acute diarrhoea in young children in the tropics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of Saccharomyces boulardii in children with acute diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in pediatric gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Clinical efficacy of probiotics: review of the evidence with focus on children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics for children: use in diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A pilot trial of Saccharomyces boulardii in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in the treatment of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Pouchitis: result of microbial imbalance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Microbial-gut interactions in health and disease. Irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Bacillus clausii effects in children with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Treatment of perennial allergic rhinitis with lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Laser acupuncture and probiotics in school age children with asthma: a randomized, placebo-controlled pilot study of therapy guided by principles of Traditional Chinese Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Reversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Failure to improve parameters of lactose maldigestion using the multiprobiotic product VSL3 in lactose maldigesters: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics, infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics to prevent urinary tract infections: the rationale and evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Probiotics and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Recommendations for probiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F14732300080360S101

10.1177/14732300080360S101

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference